Oncology - Anemia/Polycythemia News & Articles

181 Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease Clinical Gastroenterology and Hepatology , March 5, 2013    Clinical Article

182 Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia Transfusion Medicine, March 5, 2013    Clinical Article

183 Chronic and severe neutropenia in adulthood Hematologie, March 5, 2013    Clinical Article

184 Dynamics of Anemia in Relation to Parasitic Infections, Micronutrient Status, and Growing Age in South-Central Cote dIvoire The Journal of Infectious Diseases, March 4, 2013    Clinical Guideline

185 A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia Full Text Haematologica, March 4, 2013    Clinical Article

186 Prevalence of pneumococcal vaccination in adult immune thrompocytopenia patients exposed to rituximab or to splenectomy European Journal of Haematology, March 4, 2013    Clinical Article

187 Moderate Aplastic Anemia in Children: Preliminary Outcomes for Treatment Versus Observation From a Single-Institutional Experience Journal of Pediatric Hematology/Oncology, March 4, 2013    Clinical Article

188 A Novel G6PC3 Gene Mutation in a Patient With Severe Congenital Neutropenia Journal of Pediatric Hematology/Oncology, February 28, 2013    Clinical Article

189 Dengue Induces Platelet Activation, Mitochondrial Dysfunction and Cell Death through Mechanisms that Involve DC-SIGN and Caspases Journal of Thrombosis and Haemostasis, February 28, 2013    Clinical Article

190 Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity International Journal of Cardiology, February 28, 2013    Clinical Article

191 Anaemia management and mortality risk in chronic kidney disease Nature Reviews Nephrology, February 28, 2013    Clinical Article

192 Retinal changes in children and adolescents with sickle cell disease attending a paediatric hospital in Cairo, Egypt: risk factors and relation to ophthalmic and cerebral blood flow Transactions of the Royal Society of Tropical Medicine and Hygiene, February 28, 2013    Clinical Article

193 A megakaryocyte with no platelets: Anti-platelet antibodies, apoptosis, and platelet production Platelets, February 27, 2013    Review Article    Clinical Article

194 Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia Blood Cells, Molecules, and Diseases, February 26, 2013    Clinical Article

195 Laboratory testing for cobalamin deficiency in megaloblastic anemia American Journal of Hematology, February 25, 2013    Clinical Article

196 Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype Journal of the American Society of Nephrology, February 25, 2013    Review Article

197 Comparison of discriminative indices for iron deficiency anemia and β thalassemia trait in a Brazilian population Hematology, February 25, 2013    Review Article

198 Spectrum of α-thalassemia mutations including first observation of - -FIL deletion in Hatay Province, Turkey Blood Cells, Molecules, and Diseases, February 22, 2013    Clinical Article

199 Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab Hematology, February 21, 2013

200 Long Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease Biology of Blood and Marrow Transplantation, February 20, 2013    Clinical Article

1 Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013 Mayo Clinic Proceedings, April 2, 2013    Clinical Guideline

2 High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia Experimental Hematology, April 12, 2013

3 Cytoreduction plus low-dose aspirin versus cytoreduction alone as primary prophylaxis of thrombosis in patients with high-risk essential thrombocythaemia: an observational study British Journal of Haematology, April 15, 2013

4 Low Serum Lipocalin Levels in Patients With Iron Deficiency Anemia Journal of Pediatric Hematology/Oncology, April 1, 2013

5 Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study Nephrology Dialysis Transplantation, April 1, 2013

6 Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia Leukemia, April 10, 2013    Review Article

7 Comparative Review of the Safety and Efficacy of Ferric Carboxymaltose Versus Standard Medical Care for the Treatment of Iron Deficiency Anemia in Bariatric and Gastric Surgery Patients Obesity Surgery, April 12, 2013    Review Article

8 Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria British Journal of Haematology, April 26, 2013

9 Hematological and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell disease Haematologica, April 3, 2013    Free full text

10 Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs The Journal of Clinical Investigation, April 25, 2013    Free full text

11 Genetic modifiers of sickle cell anemia in the BABY HUG cohort: Influence on laboratory and clinical phenotypes American Journal of Hematology, April 24, 2013

12 Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy Hematological Oncology, April 24, 2013

13 Verifying Hellström-Lindberg score as predictive tool for response to erythropoietin therapy according to the International Working Group criteria, in anemic patients affected by myelodysplastic syndrome: a monocentric experience International Journal of Hematology, April 4, 2013    Review Article

14 Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia Cancer Chemotherapy and Pharmacology, April 10, 2013

15 Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists Transfusion, March 11, 2013

16 High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM Annals of Hematology, April 10, 2013    Review Article

17 Comparison of diagnostic performance of the heparin-induced thrombocytopenia expert probability and the 4Ts score in screening for heparin-induced thrombocytopenia Blood Coagulation & Fibrinolysis, April 10, 2013

18 Chemotherapy-induced anemia: the story of darbepoetin alfa Current Medical Research and Opinion, April 10, 2013    Review Article

19 Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia Journal of Clinical Oncology, April 5, 2013

20 Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia Annals of Oncology, April 15, 2013